Literature DB >> 30414963

RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.

Yuqing Feng1, Lai Wong1, Michael Morse2, Ioulia Rouzina3, Mark C Williams2, Linda Chelico4.   

Abstract

Human APOBEC3H is a single-stranded (ss)DNA deoxycytidine deaminase that inhibits replication of retroelements and HIV-1 in CD4+ T cells. When aberrantly expressed in lung or breast tissue, APOBEC3H can contribute to cancer mutagenesis. These different activities are carried out by different haplotypes of APOBEC3H. Here we studied APOBEC3H haplotype II, which is able to restrict HIV-1 replication and retroelements. We determined how the dimerization mechanism, which is mediated by a double-stranded RNA molecule, influenced interactions with and activity on ssDNA. The data demonstrate that the cellular RNA bound by APOBEC3H does not completely inhibit enzyme activity, in contrast to other APOBEC family members. Despite degradation of the cellular RNA, an approximately 12-nt RNA remains bound to the enzyme, even in the presence of ssDNA. The RNA-mediated dimer is disrupted by mutating W115 on loop 7 or R175 and R176 on helix 6, but this also disrupts protein stability. In contrast, mutation of Y112 and Y113 on loop 7 also destabilizes RNA-mediated dimerization but results in a stable enzyme. Mutants unable to bind cellular RNA are unable to bind RNA oligonucleotides, oligomerize, and deaminate ssDNA in vitro, but ssDNA binding is retained. Comparison of A3H wild type and Y112A/Y113A by fluorescence polarization, single-molecule optical tweezer, and atomic force microscopy experiments demonstrates that RNA-mediated dimerization alters the interactions of A3H with ssDNA and other RNA molecules. Altogether, the biochemical analysis demonstrates that RNA binding is integral to APOBEC3H function.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  APOBEC3H; HIV-1; enzyme–DNA interactions; enzyme–RNA interactions; restriction factor

Mesh:

Substances:

Year:  2018        PMID: 30414963      PMCID: PMC6289724          DOI: 10.1016/j.jmb.2018.11.006

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  73 in total

Review 1.  Fluorescence polarization/anisotropy in diagnostics and imaging.

Authors:  David M Jameson; Justin A Ross
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

3.  A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.

Authors:  Rahul M Kohli; Shaun R Abrams; Kiran S Gajula; Robert W Maul; Patricia J Gearhart; James T Stivers
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

4.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

5.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

6.  Cytidine deamination induced HIV-1 drug resistance.

Authors:  Lubbertus C F Mulder; Ariana Harari; Viviana Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

7.  HIV-1 Vif adaptation to human APOBEC3H haplotypes.

Authors:  Marcel Ooms; Bonnie Brayton; Michael Letko; Susan M Maio; Christopher D Pilcher; Frederick M Hecht; Jason D Barbour; Viviana Simon
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

8.  Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.

Authors:  Mithun Mitra; Dustin Singer; Yu Mano; Jozef Hritz; Gabriel Nam; Robert J Gorelick; In-Ja L Byeon; Angela M Gronenborn; Yasumasa Iwatani; Judith G Levin
Journal:  Retrovirology       Date:  2015-01-22       Impact factor: 4.602

9.  RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.

Authors:  Hendrik Huthoff; Flavia Autore; Sarah Gallois-Montbrun; Franca Fraternali; Michael H Malim
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

10.  Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.

Authors:  Eun-Young Kim; Ramon Lorenzo-Redondo; Susan J Little; Yoon-Seok Chung; Prabhjeet K Phalora; Irina Maljkovic Berry; John Archer; Sudhir Penugonda; Will Fischer; Douglas D Richman; Tanmoy Bhattacharya; Michael H Malim; Steven M Wolinsky
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

View more
  8 in total

1.  HIV restriction factor APOBEC3G binds in multiple steps and conformations to search and deaminate single-stranded DNA.

Authors:  Michael Morse; M Nabuan Naufer; Yuqing Feng; Linda Chelico; Ioulia Rouzina; Mark C Williams
Journal:  Elife       Date:  2019-12-18       Impact factor: 8.140

2.  Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.

Authors:  Jennifer A Bohn; Justin DaSilva; Siarhei Kharytonchyk; Maria Mercedes; Jennifer Vosters; Alice Telesnitsky; Theodora Hatziioannou; Janet L Smith
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  APOBEC3A is a prominent cytidine deaminase in breast cancer.

Authors:  Luis M Cortez; Amber L Brown; Madeline A Dennis; Christopher D Collins; Alexander J Brown; Debra Mitchell; Tony M Mertz; Steven A Roberts
Journal:  PLoS Genet       Date:  2019-12-16       Impact factor: 5.917

4.  The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.

Authors:  Milaid Granadillo Rodríguez; Ben Flath; Linda Chelico
Journal:  Open Biol       Date:  2020-12-09       Impact factor: 6.411

Review 5.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

6.  Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.

Authors:  Mollie M McDonnell; Suzanne C Karvonen; Amit Gaba; Ben Flath; Linda Chelico; Michael Emerman
Journal:  PLoS Pathog       Date:  2021-06-25       Impact factor: 6.823

Review 7.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

8.  Polymorphisms in Human APOBEC3H Differentially Regulate Ubiquitination and Antiviral Activity.

Authors:  Nicholas M Chesarino; Michael Emerman
Journal:  Viruses       Date:  2020-03-30       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.